MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55

References

• Kroemer G, Senovilla L, Galluzzi L, Andre F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med. 2015;21(10):1128–38. doi:10.1038/nm.3944. PMID:26444637.
   PubMed Web of Science ®Google Scholar
• Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H, kConFab BDR, Li J, et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet. 2012;8(9):e1002894. doi:10.1371/journal.pgen.1002894. PMID:23028338.
   PubMed Web of Science ®Google Scholar
• Yu L, Yang Y, Hou J, Zhai C, Song Y, Zhang Z, Qiu L, Jia X. MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells. Oncol Rep. 2015;34(4):52. doi:10.3892/or.2015.4173. PMID:26252024.
   PubMed Web of Science ®Google Scholar
• Spanheimer PM, Carr JC, Thomas A, Sugg SL, Scott-Conner CE, Liao J, Weigel RJ. The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer. Am J Surg. 2013;206(1):2–7. doi:10.1016/j.amjsurg.2012.10.025. PMID:23375759.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jin T, Dai X, Xu J. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells. Biosci Trends. 2016;10(1):67–73. doi:10.5582/bst.2016.01010. PMID:26902787.
   PubMed Web of Science ®Google Scholar
• Chen L, Li Y, Fu Y, Peng J, Mo MH, Stamatakos M, Teal CB, Brem RF, Stojadinovic A, Grinkemeyer M, et al. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One. 2013;8(1):e54213. doi:10.1371/journal.pone.0054213. PMID:23372687.
   PubMed Web of Science ®Google Scholar
• Tang J, Ahmad A, Sarkar FH. The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci. 2012;13(10):13414–37. doi:10.3390/ijms131013414. PMID:23202960.
   PubMed Web of Science ®Google Scholar
• Nygren MK, Tekle C, Ingebrigtsen VA, Makela R, Krohn M, Aure MR, Nunes-Xavier CE, Perala M, Tramm T, Alsner J, et al. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c. Br J Cancer. 2014;110(8):2072–80. doi:10.1038/bjc.2014.113. PMID:24577056.
   PubMed Web of Science ®Google Scholar
• Kalniete D, Nakazawa-Miklasevica M, Strumfa I, Abolins A, Irmejs A, Gardovskis J, Miklasevics E. High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients. Hered Cancer Clin Pract. 2015;13(1):7. doi:10.1186/s13053-015-0028-z. PMID:25705321.
   PubMedGoogle Scholar
• Hu H, Gatti RA. MicroRNAs: new players in the DNA damage response. J Mol Cell Biol. 2011;3(3):151–8. doi:10.1093/jmcb/mjq042. PMID:21183529.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R, et al. miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med. 2014;12:224. doi:10.1186/s12916-014-0224-0. PMID:25465851.
   PubMed Web of Science ®Google Scholar
• Bao H, Li X, Li H, Xing H, Xu B, Zhang X, Liu Z. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX. J Biosci. 2017;42(1):103–11. PMID:28229969
   PubMed Web of Science ®Google Scholar
• Pan HL, Wen ZS, Huang YC, Cheng X, Wang GZ, Zhou YC, Wang ZY, Guo YQ, Cao Y, Zhou GB. Down-regulation of microRNA-144 in air pollution-related lung cancer. Sci Rep. 2015;5:14331. doi:10.1038/srep14331. PMID:26395400
   PubMed Web of Science ®Google Scholar
• Sun J, Shi R, Zhao S, Li X, Lu S, Bu H, Ma X, Su C. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle. J Exp Clin Cancer Res. 2017;36(1):40. doi:10.1186/s13046-017-0504-6. PMID:28270228.
   PubMed Web of Science ®Google Scholar
• Chang YC, Wu CH, Yen TC, Ouyang P. Centrosomal protein 55 (Cep55) stability is negatively regulated by p53 protein through Polo-like kinase 1 (Plk1). J Biol Chem. 2012;287(6):4376–85. doi:10.1074/jbc.M111.289108. PMID:22184120.
   PubMed Web of Science ®Google Scholar
• Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y, et al. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell. 2005;9(4):477–88. doi:10.1016/j.devcel.2005.09.003. PMID:16198290.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang Z, Chen G, Jia Y. Prognostic significance of centrosomal protein 55 in stage I pulmonary adenocarcinoma after radical resection. Thorac Cancer. 2016;7(3):316–22. doi:10.1111/1759-7714.12330. PMID:27148417.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wang Z, Jia Y. CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma. Oncol Lett. 2017;13(1):236–42. doi:10.3892/ol.2016.5414. PMID:28123547.
   PubMed Web of Science ®Google Scholar
• Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, Araiza-Chavez J, Trevino V, Rodriguez-Padilla C, Resendez-Perez D. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac J Clin Oncol. 2013;9(1):53–9. doi:10.1111/j.1743-7563.2012.01548.x. PMID:22898264.
   PubMed Web of Science ®Google Scholar
• Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, et al. miR-214 and miR-148b Targeting inhibits dissemination of Melanoma and Breast Cancer. Cancer Res. 2016;76(17):5151–62. doi:10.1158/0008-5472.CAN-15-1322. PMID:27328731.
   PubMed Web of Science ®Google Scholar
• Shimono Y, Mukohyama J, Nakamura S, Minami H. MicroRNA Regulation of Human Breast cancer stem cells. J Clin Med. 2015;5(1):2. doi:10.3390/jcm5010002. PMID:26712794.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–22. doi:10.1038/nrd.2016.246. PMID:28209991.
   PubMed Web of Science ®Google Scholar
• Guo L, Yuan J, Xie N, Wu H, Chen W, Song S, Wang X. miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer. Mol Med Rep. 2016;14(4):2975–82. doi:10.3892/mmr.2016.5645. PMID:27572271.
   PubMed Web of Science ®Google Scholar
• Madhavan D, Peng C, Wallwiener M, Zucknick M, Nees J, Schott S, Rudolph A, Riethdorf S, Trumpp A, Pantel K, et al. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis. Carcinogenesis. 2016;37(5):461–70. doi:10.1093/carcin/bgw008. PMID:26785733.
   PubMed Web of Science ®Google Scholar
• Peng T, Zhou W, Guo F, Wu HS, Wang CY, Wang L, Yang ZY. Centrosomal protein 55 activates NF-kappaB signalling and promotes pancreatic cancer cells aggressiveness. Sci Rep. 2017;7(1):5925. doi:10.1038/s41598-017-06132-z. PMID:28724890.
   PubMedGoogle Scholar
• Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ, Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, et al. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene. 2007;26(29):4272–83. doi:10.1038/sj.onc.1210207. PMID:17237822.
   PubMed Web of Science ®Google Scholar
• Sakai M, Shimokawa T, Kobayashi T, Matsushima S, Yamada Y, Nakamura Y, Furukawa Y. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene. 2006;25(3):480–6. doi:10.1038/sj.onc.1209051. PMID:16170351.
   PubMed Web of Science ®Google Scholar
• Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W, Xie K, Tang J, Zhang X, Wang L, et al. CEP55 contributes to human gastric carcinoma by regulating cell proliferation. Tumour Biol. 2014;35(5):4389–99. doi:10.1007/s13277-013-1578-1. PMID:24390615.
   PubMedGoogle Scholar
• Chen S, Li P, Li J, Wang Y, Du Y, Chen X, Zang W, Wang H, Chu H, Zhao G, et al. MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR. Cell Physiol Biochem. 2015;35(3):997–1007. doi:10.1159/000369755. PMID:25660220.
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang J, Fu H, Shen L. miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process. Onco Targets Ther. 2016;9:6247–55. doi:10.2147/OTT.S103650. PMID:27785072.
   PubMed Web of Science ®Google Scholar